Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Epigenetic dysregulation of the polycomb axis in Acute Myeloid Leukemia: Clinical and prognostic correlates

Blood (2025) 146 (Supplement 1): 7035.

https://doi.org/10.1182/blood-2025-7035

Published: 2025

Journal Articles

The Impact of the number of cytogenetic abnormalities on clinical outcomes in Acute Myeloid Leukemia with complex karyotype

Blood (2025) 146 (Supplement 1): 1628.

https://doi.org/10.1182/blood-2025-1628

Published: 2025

Journal Articles

Risk of venous and arterial thromboembolic events following CAR-T therapy in relapsed or refractory non-Hodgkin lymphoma: A propensity-matched multicenter analysis.

Faris Naffa, Moath Albliwi, Firas Anaya, Rahaf Yaghi, Kirti Arora, Shrishti Sinha, Mohammed Aloqaily, Mohammad Aljarbouah, Moaath Mustafa Ali

Blood (2025) 146 (Supplement 1): 3729.

https://doi.org/10.1182/blood-2025-3729

Published: 2025

Journal Articles

Spliceosome mutations in AML: Prevalence, clinical features, and treatment outcomes in a contemporary cohort

Blood (2025) 146 (Supplement 1): 3396.

https://doi.org/10.1182/blood-2025-3396

Published: 2025

Journal Articles

Impact of age on outcomes of CAR-T cell therapy in multiple myeloma, DLBCL, and follicular lymphoma: A real-world multi-center propensity-matched analysis

Mohammed Aloqaily, Moath Albliwi, Rahaf Yaghi, Alexander Rabadi, Kirti Arora, Faris Naffa, Abdallah Al-Muhtaseb, Moaath Mustafa Ali

Blood (2025) 146 (Supplement 1): 2773.

https://doi.org/10.1182/blood-2025-2773

Published: 2025

Journal Articles

Clinical significance of RAS-MAPK pathway mutations in Acute Myeloid Leukemia: Insights from a retrospective cohort

Blood (2025) 146 (Supplement 1): 5185.

https://doi.org/10.1182/blood-2025-5185

Published: 2025

Journal Articles

Thromboembolic and cardiovascular events after CAR-T cell therapy in multiple myeloma: A propensity-matched real-world analysis

Moath Albliwi, Firas Anaya, Rahaf Yaghi, Faris Naffa', Mohammed Aloqaily, Shrishti Sinha, Kirti Arora, Mustafa Tawaha, Ayham Hussein, Abdo Haddad, Hamed Daw, Wahid Aloweiwi, Moaath Mustafa Ali

Blood (2025) 146 (Supplement 1): 2249.

https://doi.org/10.1182/blood-2025-2249

Published: 2025

Journal Articles

Increased risk of gastrointestinal complications in older adults with multiple myeloma: A propensity matched nationwide cohort study

Kirti Arora, Rishi Chowdhary, Aditi Arora, Moath Albliwi, Rachel Mcnulty, Preksha Singh, Juhi Chovatiya, Manzer Ali, Kashish Magnani, Shahzad Raza

Blood (2025) 146 (Supplement 1): 8126.

https://doi.org/10.1182/blood-2025-8126

Published: 2025

Journal Articles

Early detection of advanced-stage DLBCL using random forest: Uncovering large-scale demographic disparities and site-specific risk patterns

Junho Song, Shrishti Sinha, Asfand Yar Cheema, Jessica Santucci, Mishaal Munir, Moath Albliwi

Blood (2025) 146 (Supplement 1): 7194.

https://doi.org/10.1182/blood-2025-7194

Published: 2025

Journal Articles

Impact of cohesin complex gene mutations on clinical outcomes in Acute Myeloid Leukemia

Blood (2025) 146 (Supplement 1): 4626.

https://doi.org/10.1182/blood-2025-4626

Published: 2025

Journal Articles

TP53 and PPM1D mutations in AML: Distinct frequencies, shared pathway, and adverse prognostic trends

Blood (2025) 146 (Supplement 1): 5168.

https://doi.org/10.1182/blood-2025-5168

Published: 2025

Journal Articles

Prognostic impact of mutations in the DNA methylation pathway on clinical outcomes in acute myeloid leukemia: A retrospective cohort study

Blood (2025) 146 (Supplement 1): 5254.

https://doi.org/10.1182/blood-2025-5254

Published: 2025

Journal Articles

Comparative neuropsychiatric outcomes of ibrutinib and acalabrutinib in patients with chronic lymphocytic leukemia: A propensity-matched real-world cohort study

Kirti Arora, Yuvraj Kaushal, Moath Albliwi, Aditi Arora, Manzer Ali, Kashish Magnani, Preksha Singh, Samneet Singh Arora, Alec Ingros, Rishi Chowdhary, Laurie Matt-Amaral

Blood (2025) 146 (Supplement 1): 6335.

https://doi.org/10.1182/blood-2025-6335

Published: 2025

Journal Articles

T-lymphoblastic lymphoma presenting as pericardial tamponade: A rare initial manifestation of an aggressive malignancy

Mohammed Aloqaily, Laith Rhabneh, Ra'ed Ababneh, Mohammed Alkhanafsa, Moath Albliwi, Shahd Qaddour, Alexander Rabadi, Abdallah Al-Muhtaseb, Faris Naffa, Hussam Telfah

Blood (2025) 146 (Supplement 1): 6849.

https://doi.org/10.1182/blood-2025-6849

Published: 2025

Journal Articles

Random survival forest improves prediction of overall mortality among DLBCL patients against conventional cox models: A SEER database analysis.

Shrishti Sinha, Junho Song, Asfand Yar Cheema, Moath Albliwi, Mishaal Munir

Blood (2025) 146 (Supplement 1): 7190.

https://doi.org/10.1182/blood-2025-7190

Published: 2025

Journal Articles

Risk of thrombotic and bleeding events in patients with MPNs - does SSRI use have an impact?

Kirti Arora, Priyansh Faldu, Aditi Arora, Rishi Chowdhary, Moath Albliwi, Manzer Ali, Abhay Singh, Sandra Mazzoni

Blood (2025) 146 (Supplement 1): 2858.

https://doi.org/10.1182/blood-2025-2858

Published: 2025

Journal Articles

Immune checkpoint Inhibitors' impact on outcomes of relapsed and refractory Hodgkin lymphoma: A real-world study

Moath Albliwi, Mohamad-Noor Abu-Hammour, Rahaf Yaghi, Ameed Bawwab, Abdo Haddad, Hamed Daw, Moaath Mustafa Ali

Blood (2025) 146 (Supplement 1): 3627.

https://doi.org/10.1182/blood-2025-3627

Published: 2025

Journal Articles

Outcomes of Blast-Phase MPN and JAK2 , MPL , and CALR Mutated de Novo AML Compared to AML with Wild-Type JAK2 , MPL , and CALR Genes: A Propensity Score-Adjusted Cohort Study

Blood (2024) 144 (Supplement 1): 2868.

https://doi.org/10.1182/blood-2024-207748

Published: 2024

Journal Articles

Impact of Cytogenetic Response on Long-Term Survival in Acute Myeloid Leukemia: A Retrospective Cohort Study

Blood (2024) 144 (Supplement 1): 2862.

https://doi.org/10.1182/blood-2024-202134

Published: 2024

Journal Articles

Salvage Reinduction Chemotherapy Versus Alternative Regimens after Failed AML Intensive Induction Regimen, a Single Center Experience

Blood (2024) 144 (Supplement 1): 2848.

https://doi.org/10.1182/blood-2024-202525

Published: 2024

Update search

NARROW

Publications

Format

Article Type

Date

Availability

Epigenetic dysregulation of the polycomb axis in Acute Myeloid Leukemia: Clinical and prognostic correlates

The Impact of the number of cytogenetic abnormalities on clinical outcomes in Acute Myeloid Leukemia with complex karyotype

Risk of venous and arterial thromboembolic events following CAR-T therapy in relapsed or refractory non-Hodgkin lymphoma: A propensity-matched multicenter analysis.

Spliceosome mutations in AML: Prevalence, clinical features, and treatment outcomes in a contemporary cohort

Impact of age on outcomes of CAR-T cell therapy in multiple myeloma, DLBCL, and follicular lymphoma: A real-world multi-center propensity-matched analysis

Clinical significance of RAS-MAPK pathway mutations in Acute Myeloid Leukemia: Insights from a retrospective cohort

Thromboembolic and cardiovascular events after CAR-T cell therapy in multiple myeloma: A propensity-matched real-world analysis

Increased risk of gastrointestinal complications in older adults with multiple myeloma: A propensity matched nationwide cohort study

Early detection of advanced-stage DLBCL using random forest: Uncovering large-scale demographic disparities and site-specific risk patterns

Impact of cohesin complex gene mutations on clinical outcomes in Acute Myeloid Leukemia

TP53 and PPM1D mutations in AML: Distinct frequencies, shared pathway, and adverse prognostic trends

Prognostic impact of mutations in the DNA methylation pathway on clinical outcomes in acute myeloid leukemia: A retrospective cohort study

Comparative neuropsychiatric outcomes of ibrutinib and acalabrutinib in patients with chronic lymphocytic leukemia: A propensity-matched real-world cohort study

T-lymphoblastic lymphoma presenting as pericardial tamponade: A rare initial manifestation of an aggressive malignancy

Random survival forest improves prediction of overall mortality among DLBCL patients against conventional cox models: A SEER database analysis.

Risk of thrombotic and bleeding events in patients with MPNs - does SSRI use have an impact?

Immune checkpoint Inhibitors' impact on outcomes of relapsed and refractory Hodgkin lymphoma: A real-world study

Outcomes of Blast-Phase MPN and JAK2 , MPL , and CALR Mutated de Novo AML Compared to AML with Wild-Type JAK2 , MPL , and CALR Genes: A Propensity Score-Adjusted Cohort Study

Impact of Cytogenetic Response on Long-Term Survival in Acute Myeloid Leukemia: A Retrospective Cohort Study

Salvage Reinduction Chemotherapy Versus Alternative Regimens after Failed AML Intensive Induction Regimen, a Single Center Experience

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only